These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22411527)

  • 1. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA.
    Shi S; Liu J; Joshi SB; Krasnoperov V; Gill P; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Jun; 101(6):1969-84. PubMed ID: 22411527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
    Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?
    Chang L; Shepherd D; Sun J; Ouellette D; Grant KL; Tang XC; Pikal MJ
    J Pharm Sci; 2005 Jul; 94(7):1427-44. PubMed ID: 15920775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.
    Scehnet JS; Ley EJ; Krasnoperov V; Liu R; Manchanda PK; Sjoberg E; Kostecke AP; Gupta S; Kumar SR; Gill PS
    Blood; 2009 Jan; 113(1):254-63. PubMed ID: 18836096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and stabilization of recombinant human protein pentraxin (rhPTX-2).
    Liu J; Blasie CA; Shi S; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Mar; 102(3):827-41. PubMed ID: 23160921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of a hydrophobic recombinant cytokine by human serum albumin.
    Hawe A; Friess W
    J Pharm Sci; 2007 Nov; 96(11):2987-99. PubMed ID: 17786949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphB4 as a therapeutic target in mesothelioma.
    Liu R; Ferguson BD; Zhou Y; Naga K; Salgia R; Gill PS; Krasnoperov V
    BMC Cancer; 2013 May; 13():269. PubMed ID: 23721559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective domain stabilization as a strategy to reduce fusion protein aggregation.
    Cordes AA; Platt CW; Carpenter JF; Randolph TW
    J Pharm Sci; 2012 Apr; 101(4):1400-9. PubMed ID: 22234888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Serum Albumin, a Suitable Candidate to Stabilize Freeze-Dried IgG in Combination with Trehalose: Central Composite Design.
    Nouraei MS; Faghihi H; Najafabadi AR; Zadeh AHM; Darabi M; Vatanara A
    AAPS PharmSciTech; 2019 Oct; 20(8):327. PubMed ID: 31659590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
    He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of proteins by recombinant human gelatins.
    Thyagarajapuram N; Olsen D; Middaugh CR
    J Pharm Sci; 2007 Dec; 96(12):3304-15. PubMed ID: 17542020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of etanercept stability as exposed to various sugars with biophysical assessment.
    Lim DG; Kim NA; Lim JY; Kim KH; Hada S; Jeong SH
    Int J Pharm; 2014 Dec; 476(1-2):50-9. PubMed ID: 25269011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering.
    Zhao HL; Yao XQ; Xue C; Wang Y; Xiong XH; Liu ZM
    Protein Expr Purif; 2008 Sep; 61(1):73-7. PubMed ID: 18541441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective domain stabilization as a strategy to reduce human serum albumin-human granulocyte colony stimulating factor aggregation rate.
    Cordes AA; Carpenter JF; Randolph TW
    J Pharm Sci; 2012 Jun; 101(6):2009-16. PubMed ID: 22422106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of the free sulfhydryl group in the human serum albumin (HSA) moiety of human interferon-alpha2b and HSA fusion protein increases its stability against mechanical and thermal stresses.
    Zhao HL; Xue C; Wang Y; Sun B; Yao XQ; Liu ZM
    Eur J Pharm Biopharm; 2009 Jun; 72(2):405-11. PubMed ID: 19462475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on the interaction of newly designed anticancer Pd(II) complexes with different aliphatic tails and human serum albumin.
    Divsalar A; Bagheri MJ; Saboury AA; Mansoori-Torshizi H; Amani M
    J Phys Chem B; 2009 Oct; 113(42):14035-42. PubMed ID: 19778061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification, and characterization of recombinant human serum albumin fusion protein with two human glucagon-like peptide-1 mutants in Pichia pastoris.
    Dou WF; Lei JY; Zhang LF; Xu ZH; Chen Y; Jin J
    Protein Expr Purif; 2008 Sep; 61(1):45-9. PubMed ID: 18556214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical characterization of insoluble aggregates of a multi-domain protein: an insight into the role of the various domains.
    Souillac PO
    J Pharm Sci; 2005 Sep; 94(9):2069-83. PubMed ID: 16052560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trehalose Monooleate: A Potential Antiaggregation Agent for Stabilization of Proteins.
    Kale SS; Akamanchi KG
    Mol Pharm; 2016 Dec; 13(12):4082-4093. PubMed ID: 27726389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.